AIC
ZSAN

Ameritas Investment Company’s Zosano Pharma Corporation ZSAN Stock Holding History

Ameritas Investment Company’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1
Closed – – 1921
2018
Q4 		$0 Buy
+1
New +$127 ﹤0.01% 1597

Other funds holding ZSAN

ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameritas Investment Company's ZSAN Position: Q1 2019 in Review

Ameritas Investment Company sold out of Zosano Pharma Corporation (ZSAN) in Q1 2019, closing a stake of 1 share.

Ameritas Investment Company first reported a position in ZSAN in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 19 funds tracked by Wall St. Rank hold ZSAN as of Q1 2019.

  • Ameritas Investment Company reported no remaining Zosano Pharma Corporation position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 1 Zosano Pharma Corporation share in Q1 2019.
  • Ameritas Investment Company first reported a position in Zosano Pharma Corporation in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's Zosano Pharma Corporation position peaked at $0 in Q4 2018.
  • 19 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.